Amoxicillin for Oral Suspension USP, 400 mg/ 5 mL, 50 mL bottle, Rx only, Manufactured In Canada ...
FDA Drug Recall #D-1470-2016 — Class II — June 24, 2016
Recall Summary
| Recall Number | D-1470-2016 |
| Classification | Class II — Moderate risk |
| Date Initiated | June 24, 2016 |
| Status | Terminated |
| Voluntary | Voluntary: Firm initiated |
Recalling Firm
| Firm | Teva North America |
| Location | Horsham, PA |
| Product Type | Drugs |
| Quantity | 53,328 bottles |
Product Description
Amoxicillin for Oral Suspension USP, 400 mg/ 5 mL, 50 mL bottle, Rx only, Manufactured In Canada by: Teva Canada Limited, Toronto, Canada, NDC 0093-4161-76
Reason for Recall
Superpotent drug: Out of specification test result for assay during stability testing.
Distribution Pattern
Nationwide
Lot / Code Information
Lot # 35434158A, Exp 6/17
Other Recalls from Teva North America
| Recall # | Classification | Product | Date |
|---|---|---|---|
| D-0005-2017 | Class III | Claravis (isotretinoin capsules USP), 10mg, pa... | Aug 5, 2016 |
| D-1453-2016 | Class III | Children's Qnasl 40 mcg (beclomethasone dipropi... | Jul 15, 2016 |
| D-1455-2016 | Class II | Albuterol Sulfate Syrup, 2 mg/ 5 mL, 473 mL bot... | Jun 22, 2016 |
| D-1494-2016 | Class II | ARGATROBAN Injection in 0.9% Sodium Chloride 25... | Jun 17, 2016 |
| D-1495-2016 | Class II | Linezolid Injection 600 mg/300 mL Rx Only, Manu... | Jun 17, 2016 |
Frequently Asked Questions
Stop taking the medication and contact your pharmacist or doctor immediately. For Class I recalls, this is urgent. For Class II or III recalls, consult your doctor before stopping — abruptly discontinuing certain medications (blood pressure drugs, antidepressants, diabetes medications) can be more harmful than continuing while arranging a replacement. Check whether the recall applies to your specific lot number and expiration date. Return the product to your pharmacy and report any adverse effects to FDA MedWatch at 1-800-FDA-1088.
Not necessarily. Many drug recalls are initiated because of quality system failures or test results that suggest a product might not meet specifications — even if no patients have reported harm. The FDA uses a precautionary approach: if there is reason to believe quality standards were not met, a recall is required regardless of whether adverse effects have been reported. Class I recalls typically involve a reasonable probability of harm; Class II recalls may cause temporary health issues; Class III recalls are for products unlikely to cause adverse health consequences but that still violate regulations.
Pharmacies typically receive recall notices directly from drug wholesalers and manufacturers within days of the recall being announced. Your pharmacist can look up whether any product in your prescription history matches a recalled lot number. For current recalls, the FDA publishes updates at FDA.gov/safety/recalls-market-withdrawals-safety-alerts and sends MedWatch email alerts for significant drug safety issues. You can sign up for MedWatch alerts at FDA.gov. Most major pharmacy chains also have their own recall notification systems that automatically alert pharmacists when a recalled product is in their inventory.
What Should You Do?
Stop using this medication if affected by this recall. Contact your pharmacist or prescribing doctor immediately for guidance. Do not flush medications — use a drug take-back program.